15.01.2013
- AstraZeneca's new chief executive stamped his authority on the struggling drugmaker on Tuesday by removing the heads of research and commercial operations. Pascal Soriot, who took...
29.10.2012
- Struggling British drugmaker AstraZeneca is giving its new chief executive Pascal Soriot 4 million pounds ($6.44 million) compensation for loss of long-term incentives from his...
25.10.2012
- AstraZeneca's sales slumped 19% in the third quarter, underscoring the scale of the challenge confronting the drugmaker's new chief executive, Pascal Soriot. Faced with patent...
01.10.2012
- AstraZeneca has suspended its share buyback program, giving new chief executive Pascal Soriot more leeway to devise a strategy to return the British drugmaker to growth. The...
28.08.2012
- AstraZeneca has poached Pascal Soriot from rival Roche Holding to be its new chief executive, hoping his track record in drug innovation and dealmaking can revive a company...
